Proposal to list medical devices supplied by Device Technologies New Zealand Pty Limited
Te Pātaka Whaioranga - Pharmac is seeking feedback on a proposal to list a range of medical devices in Part III of Section H of the Pharmaceutical Schedule.
What we’re proposing
Pharmac is seeking feedback on a proposal to list medical devices supplied by Device Technologies New Zealand Pty Limited (“Device Technologies”) in Part III of Section H of the Pharmaceutical Schedule from 1 April 2024 in the following category:
Consultation closes at 4pm Tuesday 5 March 2024 and feedback can be emailed to kendra.boyes@pharmac.govt.nz.
What would the effect be?
From 1 April 2024, medical devices in the adhesives, sealants, and haemostats category that are supplied by Device Technologies would be listed under a proposed national agreement for all Te Whatu Ora hospitals to purchase under, subject to consultation and approval by Pharmac’s Board or delegate (“Agreement”).
The Agreement would not be for sole supply and Te Whatu Ora hospitals could continue to purchase other suppliers’ brands of adhesives, sealants, and haemostats.
The Agreement would supersede any existing Te Whatu Ora contracts with Device Technologies for the products included in the Agreement. Any medical devices listed in the Agreement and purchased by Te Whatu Ora hospitals would be in accordance with the terms and conditions, including price, stated in the Agreement effective from the date of listing on the Pharmaceutical Schedule.
Pricing for the medical devices in the Agreement, subject to any prior termination of the Agreement, would not be increased without prior consultation and approval by Pharmac.
Who we think will be interested
- Te Whatu Ora staff in a range of different clinical settings including but not limited to:
- Emergency service personnel
- General ward clinicians and nurses
- Operating theatre nurses
- Surgeons
- Procurement and supply chain personnel
- Suppliers and wholesalers
About the medical devices
Adhesives, sealants and haemostats
Adhesives, sealants, and haemostats are medical devices used in surgical and non-surgical procedures to achieve haemostasis, tissue sealing, fixation and/or wound closure. The products vary relating to their purpose, function, composition, application and clinical indication. There are adhesive, sealant, and haemostat products used in general surgical applications, as well as products designed and used for specific clinical indications/specialty areas.
Why we’re proposing this
In February 2023 Pharmac issued the following Request for Proposals (RFP):
The RFP was for non-exclusive national agreements for listing on the Pharmaceutical Schedule.
Pharmac has been working with suppliers who responded to the RFP and were successful in being progressed to contract negotiation to seek provisional agreements. This proposal consists of the latest agreement to arise from this process and we expect to consult on further provisional agreements with suppliers in this category throughout 2024.
Details about our proposal
The proposal would result in listing 14 medical devices from the Glubran Tiss and Glubran brands in the adhesives, sealants, and haemostats category on the Pharmaceutical Schedule.
Further information, including pricing and contractual details, has been provided to Te Whatu Ora Procurement personnel. Clinicians interested in further detail on what this change means for their Te Whatu Ora Hospital should engage with their Procurement teams.
To provide feedback
Send us an email: kendra.boyes@pharmac.govt.nz by 4pm Tuesday 5 March 2024.
All feedback received before the closing date will be considered by Pharmac’s Board (or its delegate) prior to making a decision on this proposal.
Your feedback may be shared
Feedback we receive is subject to the Official Information Act 1982 (OIA). Please be aware that we may need to share your feedback, including your identity, in response to an OIA request. This applies to anyone providing feedback, whether they are providing feedback themselves or for an organisation, in a personal or professional capacity.
We can only keep feedback confidential as allowed under the OIA and other related laws. If you want any part of your feedback treated as confidential, you need to tell us. Please let us know if you want to keep part of your feedback confidential, and why. Is it commercially sensitive, confidential or proprietary, or personal information? Clearly state this and tell us which parts of your feedback you want to keep confidential for these reasons. We will consider your request under our OIA requirements.